Bristol-Myers Inks $440M Sales Deal With Reckitt Benckiser
Law360, Los Angeles (February 12, 2013, 7:41 PM EST) -- Pharmaceutical giant Bristol-Myers Squibb Co. has signed off on a $438 million collaboration agreement giving British manufacturer Reckitt Benckiser Group PLC exclusive rights to sell several of the drugmaker’s Latin American...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
